reference/21235386

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21235386

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Randomized Controlled Trial
endingPage	451
issn	1365-2265 0300-0664
issueIdentifier	4
pageRange	447-451
publicationName	Clinical Endocrinology
startingPage	447
bibliographicCitation	Jenkins PJ, Jain A, Jones SL, Besser GM, Grossman AB. Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy. Clin Endocrinol (Oxf). 1996 Oct;45(4):447–51. doi: 10.1046/j.1365-2265.1996.8240834.x. PMID: 8959084.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_533c12ac681d39861682328b6d7d6b77 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5eec480108527d4fad073618ad6f2bd8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_356f11b8a2b5cb5910e1dacec2e367d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ccc6dc13a930b6a5137c6f34c086cdd2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1f3ab17cf13f73a9cab3fe95cf90cd74
date	199610
identifier	https://doi.org/10.1046/j.1365-2265.1996.8240834.x https://pubmed.ncbi.nlm.nih.gov/8959084
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2995 https://portal.issn.org/resource/ISSN/0300-0664 https://portal.issn.org/resource/ISSN/1365-2265
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy
discusses	http://id.nlm.nih.gov/mesh/M0017460 http://id.nlm.nih.gov/mesh/M0002948 http://id.nlm.nih.gov/mesh/M0005772
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001971Q000009 http://id.nlm.nih.gov/mesh/D009325Q000517 http://id.nlm.nih.gov/mesh/D011239Q000008 http://id.nlm.nih.gov/mesh/D014839Q000517 http://id.nlm.nih.gov/mesh/D006966Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D009325Q000139 http://id.nlm.nih.gov/mesh/D011239Q000627 http://id.nlm.nih.gov/mesh/D001971Q000627 http://id.nlm.nih.gov/mesh/D001971Q000008 http://id.nlm.nih.gov/mesh/D014839Q000139 http://id.nlm.nih.gov/mesh/D007022Q000517 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D003692 http://id.nlm.nih.gov/mesh/D007022Q000139
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8136 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31101 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31100 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2646324a5fd6d7fddb3c3036ea615456 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10995 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b58825cefebdd1dec077a250ee49420e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8095 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8121

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53789332 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53790825 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53787563

Total number of triples: 66.